Page 46 - Read Online

Dai et al. Hepatoma Res 2020;6:16 I http://dx.doi.org/10.20517/2394-5079.2019.40 Page 9 of 9

virologic response: an HCV-TARGET analysis. Hepatol Commun 2019;3:1388-99.
32. Ji F, Yeo YH, Wei MT, Wei B, Dang S, et al. Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment:
Do direct-acting antiviral regimens matter? Hepatology 2018;67:1180-2.
33. Niu J, Kumar U, Monjardino J, Goldin R, Rosin D, et al. Hepatitis C virus replication in hepatocellular carcinoma. J Clin Pathol
1995;48:880-2.
34. Konjeti VR, John BV. Interaction between hepatocellular carcinoma and hepatitis C eradication with direct-acting antiviral therapy.
Curr Treat Options Gastroenterol 2018;16:203-14.
35. Sachdeva M, Chawla YK, Arora SK. Immunology of hepatocellular carcinoma. World J Hepatol 2015;7:2080-90.